Also trades as: IPA.V (TSXV)
IPA NASDAQ
ImmunoPrecise Antibodies Ltd.
1W: -2.8%
1M: +8.9%
3M: -33.1%
1Y: +258.3%
3Y: -66.4%
5Y: -75.8%
$1.62
Last traded 2025-11-17 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$18M
Revenue
-23.3% YoY
$-12M
Net Income
+73.5% YoY
$-12M
Free Cash Flow
-25.3% YoY
59.3%
Gross Margin
-88.4%
Op. Margin
-94.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-60.9%
ROA-35.6%
ROIC-218.7%
Valuation
P/E-8.2
P/B7.2
EV/EBITDA0.0
Leverage
Debt/Equity0.24
Current Ratio3.74
Interest Cov.-12470.9x
Quality Scores
Piotroski F6/9
Altman Z—
Beneish M-3.89